National hospital survey of anaerobic culture and susceptibility methods: III

Anaerobe

Volumn 14, Issue 2, 2008, Pages 68-72

  Goldstein, Ellie J C ^a,b   Citron, Diane M ^a   Goldman, Pamela J ^a   Goldman, Ronald J ^a  

^a R M ALDEN RESEARCH LABORATORY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Anaerobic susceptibility; B. fragilis; Etest; Methods

Indexed keywords

AGAR; AMOXICILLIN; AMPICILLIN; CEFOTETAN; CEFOXITIN; CHLORAMPHENICOL; CLINDAMYCIN; DOXYCYCLINE; ERTAPENEM; IMIPENEM; MEROPENEM; METRONIDAZOLE; MOXIFLOXACIN; PENICILLIN G; PIPERACILLIN PLUS TAZOBACTAM; SULTAMICILLIN; TAZOBACTAM; TIGECYCLINE;

ANAEROBIC BACTERIUM; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BACTEROIDES FRAGILIS; BLOOD CULTURE; BROTH DILUTION; CONTROLLED STUDY; CULTURE MEDIUM; ELUTION; ENZYMATIC ASSAY; EPSILOMETER TEST; HOSPITAL; LABORATORY; NONHUMAN; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZATION; SPECIES IDENTIFICATION; UNITED STATES; WOUND;

BACTERIA, ANAEROBIC; BACTERIAL INFECTIONS; BACTERIOLOGICAL TECHNIQUES; DATA COLLECTION; HEALTH SERVICES RESEARCH; HOSPITALS; HUMANS; MICROBIAL SENSITIVITY TESTS; QUESTIONNAIRES; UNITED STATES;

EID: 42249113158     PISSN: 10759964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.anaerobe.2008.01.001     Document Type: Article

References (23)

1. Goldstein E.J.C., Citron D.M., and Goldman R.J. National hospital survey of anaerobic culture and susceptibility testing methods: results and recommendations for improvement. J Clin Microbiol 30 (1992) 1529-1534
2. Goldstein E.J.C., Citron D.M., Goldman R.J., Claros M.C., and Hunt-Gerrado S. United States national hospital survey of anaerobic culture and susceptibility methods II. Anaerobe 1 (1995) 309-314
3. Lassmann B., Gustafson D.R., Wood C.M., and Rosenblatt J.E. Reemergence of anaerobic bacteremia. Clin Infect Dis 44 (2007) 895-900
4. Hecht D.W. Routine anaerobic blood cultures: back where we started?. Clin Infect Dis 45 (2007) 901-903
5. Nguyen M.H., Yu V.L., Morris A.J., McDermott L., Wagener M.W., et al. Antimicrobial resistance and clinical outcome of Bacteroides bacteremia: findings of a multicenter prospective observational trial. Clin Infect Dis 30 (2000) 870-876
6. McGregor J.C., Rich S.E., Harris A.D., Perenchevich E.N., Osih R., et al. A systematic review of the methods used to assess the association between appropriate antibiotic therapy and mortality in bacteremic patients. Clin Inf Dis 45 (2007) 329-337
7. Goldstein EJC, Citron DM, Hecht DW. Chapter XXX resistance in anaerobic bacteria. In: Fong IW, Drlica K, editors. Antimicrobial resistance and implications for the 21st century (Chapter 6, pp. 207-29) Berlin: Springer; 2007.
8. Solomkin JS, Mazuski JE, Baron EJ, Bradley J, Chow A, Dellinger EP, et al., Guidelines for the selection of anti-infective agents for complicated intraabdominal infections. Clin Infect Dis, 2008, in press.
9. American Hospital Association. American Hospital Association guide to the healthcare field (2006), American Hospital Association, Chicago
10. Clinical and Laboratory Standards Institute. Methods for antimicrobial susceptibility testing of anaerobic bacteria. Approved standard, 7th ed., CLSI document M11-A7 (2007), CLSI, Wayne, PA
11. Citron D.M. rapid identification of anaerobes in the clinical laboratory. Anaerobe 5 (1999) 109-113
12. In: Murray P.R., Baron E.J., Jorgensen J.H., Landry M.L., and Pfaller M.A. (Eds). Manual of clinical microbiology (2007), American Society for Microbiology Press, Washington, DC
13. Snydman D.R., Jacobus N.V., McDermott L.A., Ruthazer R., Goldstein E.J.C., Finegold S.M., et al. National survey on the susceptibility of Bacteroides fragilis group: report and analysis of trends for 1997-2004: a US study. Antimicrob Agents Chemother 51 (2007) 1649-1655
14. Koeth L.M., Good C.E., Appelbaum P.C., Goldstein E.J.C., Rodloff A.C., Claros M., et al. Surveillance of susceptibility patterns in 1297 European and US anaerobic and capnophilic isolates to co-amoxiclav acid and five other antimicrobial agents. J Antimicrob Chemother 53 (2004) 1039-1044
15. Golan Y., McDermott L.A., Jacobus N.V., Goldstein E.J.C., Finegold S., Harrell L.J., et al. Emergence of high-level fluoroquinolone resistance among Bacteroides species. J Antimicrob Chemother 52 (2003) 208-213
16. Finegold S.M. A century of anaerobes: a look backward and a call to arms. Clin Infect Dis 16 Suppl. 4 (1993) S453-S457
17. In: Isenberg H.D. (Ed). Clinical microbiology procedure manual. 2nd ed (2004), ASM Press, Washington, DC
18. Jousimies H.R., Summanen P., Citron D.M., Baron E.J., Wexler H.M., and Finegold S.M. Wadsworth-KTL anaerobic bacteriology manual (2002), Star Publishing Co., Belmont, CA
19. Bourgault A.M., Harkness J.L., and Rosenblatt J.E. Clinical usefulness of susceptibility testing of anaerobes. Arch Int Med 138 (1978) 1824-1827
20. Citron DM., Hecht DW. Susceptibility test methods: anaerobic bacteria. In: Manual clinical microbiology (Chapter 76, pp. 1214-22). Washington, DC: American Society Microbiology Press; 2007.
21. Citron D.M., Ostovari M.I., Karlsson A., and Goldstein E.J.C. Evaluation of the E-test for susceptibility testing of anaerobic bacteria. J Clin Microbiol 29 (1991) 2197-2203
22. Rosenblatt J.E., and Gustafson D.R. Evaluation of the Etest for the susceptibility testing of anaerobic bacteria. Diagn Microbiol Infect Dis 22 (1995) 279-284
23. Rhomberg P.R., Biedenbach D.J., and Jones R.N. Activity of BMS284756 (T-3811) tested against anaerobic bacteria Campylobacter jejuni, Helicobacter pylori, and Legionella spp. Diag Microbiol Infect Dis 40 (2001) 45-49